Previous 10 | Next 10 |
Summary Compass is a newly founded British company that is moving to commercialize the long-studied therapeutic impact of psilocybin. Both market acceptance issues and bad trip potential are risks of its psilocybin-based therapy. Compass has limited liquidity and will need significa...
Palm Beach, FL – January 26, 2023 – FinancialNewsMedia.com News Commentary – Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of these continually expanding markets. Psychedeli...
Summary Numinus reported solid improvements in operational metrics for its Wellness Clinic operations in 1Q23, including a 14% increase in client appointments relative to the prior quarter. Numinus is generating substantial revenue streams, but cash burn is a serious challenge for the c...
A legislator in the state of New Hampshire recently introduced a measure that would legalize the use and possession of psychedelics such as psilocybin and LSD by individuals aged 21 and above. Psilocybin is the main psychoactive compound found in hallucinogenic mushrooms that induces a high whe...
Summary Stephen Tobin on investing in psychedelic stocks while they're still pre-revenue. Will first-movers get the advantage? Importance of patents and cash in the industry. Why he's a big believer in Compass and Atai and not as much in Cybin or MindMed. What will move share pr...
Officials in Colorado are seeking people to join its first psychedelics advisory board, which will inform the state on how to implement psychedelics legalization after voters approved a reform measure on last year’s ballot. The state’s Department of Regulatory Agencies has provid...
Summary What makes a psychedelic company compelling? Analyst Alex Carchidi has a background in biotech and focuses on long-term growth and risk management. He shares what investors should focus on in the sector and the pros and cons of owning his top 5 psychedelic stocks. ...
Last week, legislators in New York filed a measure to legalize psychedelics such as ibogaine and psilocybin for the 2023 legislative session. The bill, which will be introduced formally this week, is being sponsored by assembly members Linda Rosenthal, Karines Reyes and Jo Anne Simon. The bill ...
Summary We dive under the hood of one of the most controversial exchange-traded funds, analyzing their moves based on recently disclosed 13F filing data. Cathie Wood is a uniquely divisive figure in the world of finance made famous by her "disruptive innovation" investment philosophy, w...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It is currently as good a time as ever for long-term investors to buy stocks. With that in mind, I decided to look for seven cheap stocks trading under $20 to buy and hold forever. There are clearly many good, ...
News, Short Squeeze, Breakout and More Instantly...
LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2024 ending June 30, 2024, a...
New research has determined that psilocybin may impact the brain. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. When ingested, it distorts an individual’s perception of time, among other changes. Researchers have observed that in animals, psilocyb...